1 not yet recruiting. .
Follow xieqing: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Pursuit of Sustained Clearance of HBsAg in Chronic Hepatitis B(CHB) Patients With Previous Interferon Treatment Using Pegylated Interferon Alpha PEG IFNα-2b monotherapy or combination therapy with NAs, NAs monotherapy group - Chronic Hepatitis b | Not yet recruiting | xieqing | 10000 | 2026-04-30 | 2026-04-17 |
Combined Modality Therapy (1) · nas (1)
China (1)
Qing Xie (1)